Synthesis and evaluation of [18F]cinacalcet for the imaging of parathyroid hyperplasia-Reference-Cited by-同舟云学术

Synthesis and evaluation of [18F]cinacalcet for the imaging of parathyroid hyperplasia

Published:2021-11 Issue: Volume:102-103 Page:97-105
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Pees Anna,Beaino Wissam,Kooijman Esther J.M.,Schreurs Maxime,Verlaan Mariska,Schuit Robert C.,Vosjan Maria J.W.D.,Engelsman Anton F.,Windhorst Albert D.,Vugts Danielle J.

Funder

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference26 articles.

1. Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism;Dong;Clin Ther,2005

2. Mechanisms of secondary hyperparathyroidism;Silver;Am J Physiol Ren Physiol,2002

3. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis;Block;N Engl J Med,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Turning Points in Cross-Disciplinary Perspective of Primary Hyperparathyroidism and Pancreas Involvements: Hypercalcemia-Induced Pancreatitis, MEN1 Gene-Related Tumors, and Insulin Resistance;International Journal of Molecular Sciences;2024-06-08

2. Expression of the Calcium-Sensing Receptor on Normal and Abnormal Parathyroid and Thyroid Tissue;Journal of Surgical Research;2024-01

3. Label-Free Mass Spectrometry-Based Quantitative Proteomics to Evaluate the Effects of the Calcium-Sensing Receptor Agonist Cinacalcet on Protein Expression in Rat Brains and Livers;Medical Science Monitor;2022-07-27